What does CUSIP 04746L104 represent in this 13F holders report?

CUSIP 04746L104 is the security identifier for ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value used to aggregate holder disclosures.

How many institutions held ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in Q1 2024?

73 institutional investors reported ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value for Q1 2024. Use the holders table for investor-level position and value details.

Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)

CUSIP: 04746L104

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Common Stock, $0.0001 Par Value
Shares outstanding: 9,614,000
Total 13F shares: 21,695,406
Share change: -56,562
Total reported value: $59,443,068
Put/Call ratio: 55%
Price per share: $2.74
Number of holders: 73
Value change: -$117,105
Number of buys: 34
Number of sells: 21

Quarterly Holders Quick Answers

What is CUSIP 04746L104?
CUSIP 04746L104 identifies ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 04746L104:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PERCEPTIVE ADVISORS LLC	13F	Company	56%	5,402,964	$13,129,202	—	31 Dec 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	33%	3,153,807	$7,663,751	—	31 Dec 2023	13F
VANGUARD GROUP INC	13F	Company	18%	1,698,453	$4,127,241	—	31 Dec 2023	13F
Propel Bio Management, LLC	13F	Company	16%	1,492,792	$3,627,485	—	31 Dec 2023	13F
Simplify Asset Management Inc.	13F	Company	16%	1,492,792	$3,627,485	—	31 Dec 2023	13F
BML Capital Management, LLC	13F	Company	15%	1,454,362	$3,534,100	—	31 Dec 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	12%	1,152,715	$2,801,097	—	31 Dec 2023	13F
BlackRock Finance, Inc.	13F	Company	6.9%	662,662	$1,610,269	—	31 Dec 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	4.7%	455,857	$1,107,733	—	31 Dec 2023	13F
Pathstone Holdings, LLC	13F	Company	3.9%	372,296	$904,680	—	31 Dec 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	3.6%	346,804	$842,734	—	31 Dec 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	3.2%	304,071	$738,893	—	31 Dec 2023	13F
GSA CAPITAL PARTNERS LLP	13F	Company	3.1%	300,851	$731,000	—	31 Dec 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	3.1%	298,600	$725,598	—	31 Dec 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.9%	283,327	$688,661	—	31 Dec 2023	13F
Laird Norton Wetherby Trust Company, LLC	13F	Company	2.9%	282,309	$686,011	—	31 Dec 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	2.8%	270,197	$656,579	—	31 Dec 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2.8%	265,400	$645,000	—	31 Dec 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	2.2%	212,073	$515,337	—	31 Dec 2023	13F
Nan Fung Group Holdings Ltd	13F	Company	1.9%	180,000	$437,400	—	31 Dec 2023	13F
BARCLAYS PLC	13F	Company	1.8%	173,641	$421,947	—	31 Dec 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	1.8%	170,005	$413,112	—	31 Dec 2023	13F
Potomac Capital Management, Inc.	13F	Company	1.6%	149,585	$363,492	—	31 Dec 2023	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.5%	144,145	$348,000	—	31 Dec 2023	13F
CITADEL ADVISORS LLC	13F	Company	1.1%	110,088	$267,514	—	31 Dec 2023	13F
Hans Moebius	3/4/5	Chief Medical Officer	— class O/S missing	91,482	$266,213	—	04 Jan 2024	3/4/5
STATE STREET CORP	13F	Company	1.1%	107,781	$261,908	—	31 Dec 2023	13F
Verition Fund Management LLC	13F	Company	1%	100,000	$243,000	—	31 Dec 2023	13F
Bristlecone Advisors, LLC	13F	Company	0.89%	85,306	$207,294	—	31 Dec 2023	13F
CORNERCAP INVESTMENT COUNSEL INC	13F	Company	0.78%	75,389	$183,195	—	31 Dec 2023	13F
NORTHERN TRUST CORP	13F	Company	0.56%	54,260	$131,852	—	31 Dec 2023	13F
Clarius Group, LLC	13F	Company	0.56%	53,551	$130,129	—	31 Dec 2023	13F
MORGAN STANLEY	13F	Company	0.52%	49,563	$120,438	—	31 Dec 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.51%	49,178	$119,503	—	31 Dec 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.51%	48,696	$118,332	—	31 Dec 2023	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.37%	36,045	$87,589	—	31 Dec 2023	13F
ROYAL BANK OF CANADA	13F	Company	0.37%	35,518	$86,000	—	31 Dec 2023	13F
EASTERLY INVESTMENT PARTNERS LLC	13F	Company	0.35%	33,501	$81,407	—	31 Dec 2023	13F
Integrity Financial Corp /WA	13F	Company	0.34%	32,786	$79,670	—	31 Dec 2023	13F
BRIGHTON JONES LLC	13F	Company	0.33%	32,200	$78,246	—	31 Dec 2023	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.33%	31,422	$76,355	—	31 Dec 2023	13F
Forefront Analytics, LLC	13F	Company	0.31%	29,765	$72,329	—	31 Dec 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.24%	22,778	$55,351	—	31 Dec 2023	13F
JOURNEY STRATEGIC WEALTH LLC	13F	Company	0.21%	20,538	$49,907	—	31 Dec 2023	13F
SIMON QUICK ADVISORS, LLC	13F	Company	0.21%	20,538	$49,907	—	31 Dec 2023	13F
Sargent Investment Group, LLC	13F	Company	0.19%	18,204	$44,236	—	31 Dec 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.18%	16,882	$41,023	—	31 Dec 2023	13F
Bank of New York Mellon Corp	13F	Company	0.17%	16,204	$39,376	—	31 Dec 2023	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.16%	15,559	$37,808	—	31 Dec 2023	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.16%	15,269	$37,104	—	31 Dec 2023	13F

Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q1 2024

As of 31 Mar 2024, Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,695,406 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Simplify Asset Management Inc., Propel Bio Management, LLC, BML Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, and JACOBS LEVY EQUITY MANAGEMENT, INC. This page lists 73 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

Q1 2024 holders

Holder diff

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.